Brady Todd C
- SEC CIK
- 0001579179
In the past year, 1 open-market purchase filing worth $417.5K and no sales.
Current role at each company
- ALDX Aldeyra Therapeutics, Inc.President and CEOas of Jun 5, 2026
- EVOK Evoke Pharma IncDirectoras of Dec 17, 2025
- FSTX F-star Therapeutics, Inc.Directoras of Mar 9, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $417.5K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$417.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Brady Todd C as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ALDX Aldeyra Therapeutics, Inc.
President and CEO3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2026 (view filing) | Jun 3 | 2 days | Brady Todd CPresident and CEO | PPurchase | +250.0K | $1.67 | +$417.5K | +17.0%1.72M after | |
| Mar 12, 2024 (view filing) | Mar 11-12 | 1 day | Brady Todd CPresident and CEO | SSale | −183.2K | $3.17 | −$580.4K | −11.1%1.47M after | 2 lots |
| Jun 27, 2022 (view filing) | Jun 23 | 4 days | Brady Todd CPresident and CEO | PPurchase | +17.7K | $3.36 | +$59.5K | +1.5%1.22M after |